Stage 1 mixed cellularity Hodgkin lymphoma is often highly treatable, and many patients achieve long-term remission after frontline therapy. Advances in chemotherapy, radiation techniques and targeted ...

Northwestern Medicine scientists have uncovered a key pathway controlling tumor growth in B-cell lymphomas, according to a ...

Subscribe to our newsletter for the latest sci-tech news updates. The study, published in Nature Genetics, was co-led by Michael Green, Ph.D., professor of Lymphoma/Myeloma, and Linghua Wang, MD, Ph.D ...

VCU Massey is the first U.S. site in a global phase 2a trial for PTX-100, targeting cutaneous T-cell lymphoma. The BIPAVE-001 trial is evaluating AI-081, a PD-1 and VEGF bispecific antibody, for ...

Readers will learn how veterinary oncologists stage and treat canine lymphoma using modern multi-agent chemotherapy and palliative care.

High glyphosate use is linked to elevated rates of non-Hodgkin lymphoma cancer, particularly in Iowa and the Upper Midwest, finds a new Food & Water Watch analysis. Accompanying t ...

Traits of noncancerous cells in diffuse large B-cell lymphoma (DLBCL) tumors appear to offer insight into which patients will benefit the most from chimeric antigen receptor (CAR) T-cell therapy, ...

This may make you think before you ink. A study of people in Sweden found that those who had gotten tattoos were 21% more likely to have subsequently been diagnosed with malignant lymphoma. And the ...

A report from the environmental group Food & Water Watch found that the majority of counties that are in the top 20% for glyphosate application have non-Hodgkin lymphoma rates above the national ...

As artificial intelligence (AI) tools continue to proliferate, they are becoming a go-to search tool for patients, providers, and caregivers. Blood cancer patients are using AI in oncology to help ...

The 2026 Cancer in Iowa Report, published by the Iowa Cancer Registry, is highlighting insights into cancer trends among Iowa ...